Shobana Chandrasekar
2 ta ish
Department of Biochemistry, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India. Electronic address: [email protected]
Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”
Shobana Chandrasekar, M.K. Rohith Krishnan, Umesh Kumar
MaqolaMultiple Myeloma Research and TreatmentsJournal of the Formosan Medical Association20260 iqtibosABI